| pubmed-article:12744848 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12744848 | lifeskim:mentions | umls-concept:C0019159 | lld:lifeskim |
| pubmed-article:12744848 | lifeskim:mentions | umls-concept:C1443861 | lld:lifeskim |
| pubmed-article:12744848 | pubmed:issue | 19-20 | lld:pubmed |
| pubmed-article:12744848 | pubmed:dateCreated | 2003-5-14 | lld:pubmed |
| pubmed-article:12744848 | pubmed:abstractText | We report on the findings of an exploratory review of evidence published in English from 1945 to identify the best post-exposure prophylaxis treatment and the longest acceptable interval after exposure for prophylaxis to be effective. We found no evidence that post-exposure administration of currently available immunoglobulins is effective in preventing hepatitis A infection and disease. The use of immunoglobulins for immunoprophylaxis should not be widely recommended until a systematic review of the evidence has been conducted. We recommend that active immunization to secondary contacts of exposed and vaccinated subjects be offered. | lld:pubmed |
| pubmed-article:12744848 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12744848 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12744848 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12744848 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12744848 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12744848 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:12744848 | pubmed:issn | 0264-410X | lld:pubmed |
| pubmed-article:12744848 | pubmed:author | pubmed-author:TalianiGloria... | lld:pubmed |
| pubmed-article:12744848 | pubmed:author | pubmed-author:GaetaGiovanni... | lld:pubmed |
| pubmed-article:12744848 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12744848 | pubmed:day | 2 | lld:pubmed |
| pubmed-article:12744848 | pubmed:volume | 21 | lld:pubmed |
| pubmed-article:12744848 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12744848 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12744848 | pubmed:pagination | 2234-7 | lld:pubmed |
| pubmed-article:12744848 | pubmed:dateRevised | 2005-11-16 | lld:pubmed |
| pubmed-article:12744848 | pubmed:meshHeading | pubmed-meshheading:12744848... | lld:pubmed |
| pubmed-article:12744848 | pubmed:meshHeading | pubmed-meshheading:12744848... | lld:pubmed |
| pubmed-article:12744848 | pubmed:meshHeading | pubmed-meshheading:12744848... | lld:pubmed |
| pubmed-article:12744848 | pubmed:meshHeading | pubmed-meshheading:12744848... | lld:pubmed |
| pubmed-article:12744848 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12744848 | pubmed:articleTitle | Hepatitis A: post-exposure prophylaxis. | lld:pubmed |
| pubmed-article:12744848 | pubmed:affiliation | Clinica delle Malattie Infettive, Università di Firenze, Viale Morgagni 85, 50134 Firenze, Italy. talianig@ao-careggi.toscana.it | lld:pubmed |
| pubmed-article:12744848 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12744848 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12744848 | lld:pubmed |
